Controversy in Colposcopic Management: A Canadian Survey

Journal of Obstetrics and Gynaecology Canada

Volumn 28, Issue 1, 2006, Pages 36-40

  Nelson, Gregory S ^a   Duggan, Máire A ^a   Nation, Jill G ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Atypical squamous cell; Bethesda System; Colposcopy; High grade intraepithelial lesion; Low grade intraepithelial lesion; Management

Indexed keywords

ADULT; ARTICLE; CANADA; COLPOSCOPY; FEMALE; FOLLOW UP; HUMAN; MALE; PATIENT CARE; PATIENT REFERRAL; REPEAT PROCEDURE; UTERINE CERVIX CYTOLOGY; CANCER STAGING; CLINICAL PRACTICE; DRUG CONTRAINDICATION; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PRECANCER; PREDICTION AND FORECASTING; QUESTIONNAIRE; RISK FACTOR; UNNECESSARY PROCEDURE; UTERINE CERVIX; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; UTILIZATION REVIEW; VAGINA SMEAR;

CANADA; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; COLPOSCOPY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PHYSICIAN'S PRACTICE PATTERNS; PRECANCEROUS CONDITIONS; PREDICTIVE VALUE OF TESTS; QUESTIONNAIRES; RISK FACTORS; UNNECESSARY PROCEDURES; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 39049190244     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)32051-5     Document Type: Article

References (31)

1. Canadian Cancer Society, National Cancer Institute of Canada, Statistics Canada, Provincial/Territorial Cancer Registries, Public Health Agency of Canada. Canadian Cancer Statistics 2005, Available at, Accessed September 28, 2005. http://www.ncic.cancer.ca/vgn/images/portal/cit_86751114/60/42/393678947ncic_2005stats_en.pdf.
2. The Bethesda System for reporting cervical/vaginal cytological diagnoses. Acta Cytologica 1993, 37:115-124.
3. Solomon D., Davey D., Kurman R., Moriarty A., O'Connor D., Prey M., et al. Bethesda 2001 Workshop. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002, 287:2114-2119.
4. Canadian Society of Cytology Guidelines for Practice and Quality Assurance 2005, 14. 3rd Version, Available at, Accessed October 2, 2005. http://cap.medical.org/cytology_guidelines.pdf.
5. Association of Reproductive Health Professionals Clinical Proceedings: Human Papillomavirus (HPV) and Cervical Cancer. March 2001.
6. Guido R., Schiffman M., Solomon D., Burke L. Postcolposcopy management strategies for women referred with low-grade squamous intraepithelial lesions or human papillomavirus DNA-positive atypical squamous cells of undetermined significance: a two-year prospective study. Am J Obstet Gynecol 2003, 188:1401-1405.
7. Schiffman M., Adrianza M.E. ASCUS-LSIL triage study: design, methods and characteristics of trial participants. Acta Cytologica 2000, 44:726-742.
8. Solomon D., Schiffman M., Tarone R., For the ALTS Group Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst 2001, 93:293-299.
9. Jones J.M., Sweetnam P., Hibbard B.M. The outcome of pregnancy after cone biopsy of the cervix: a case control study. Br J Obstet Gynaecol 1979, 86:913-916.
10. Kurman R.J., Henson D.E., Herbst A.L., Noller K.L., Schiffman M.H. Interim guidelines for management of abnormal cervical cytology: the 1992 National Cancer Institute Workshop. JAMA 1994, 271:1866-1869.
11. Cox J.T., Lorincz A.T., Schiffman M.H., Sherman M.E., Cullen A., Kurman R.J. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 1995, 172:946-954.
12. Ferris D.G., Wright T.C., Litaker M.S., Richart R.M., Lorincz A.T., Sun X.W., et al. Comparison of two tests for detecting carcinogenic HPV in women with Papanicolaou smear reports of ASCUS and LSIL. J Fam Pract 1998, 46:136-141.
13. Manos M.M., Kinney W.K., Hurley L.B., Sherman M.E., Shieh-Ngai J., Kurman R.J., et al. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA 1999, 281:1605-1610.
14. Wright T.C., Lorincz A., Ferris D.G., Richart R.M., Ferenczy A., Mielzynska I., et al. Reflex human papillomavirus deoxyribonucleic acid testing in women with abnormal Papanicolaou smears. Am J Obstet Gynecol 1998, 178:962-966.
15. Bergeron C., Jeannel D., Poveda J., Cassonnet P., Orth G. Human papillomavirus testing in women with mild cytologic atypia. Obstet Gynecol 2000, 95:821-827.
16. Alanen K.W., Elit L.M., Molinaro P.A., McLachlin C.M. Assessment of cytologic follow-up as the recommended management for patients with atypical squamous cells of undetermined significance or low grade squamous intraepithelial lesions. Cancer 1998, 84:5-10.
17. Ostör A.G. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 1993, 12:186-192.
18. Lindheim S.R., Smith-Nguyen G. Aggressive evaluation for atypical squamous cells in Papanicolaou smears. J Reprod Med 1990, 35:971-973.
19. Taylor R.R., Guerrieri J.P., Nash J.D., Henry M.R., O'Connor D.M. Atypical cervical cytology. Colposcopic follow-up using the Bethesda System. J Reprod Med 1993, 38:443-447.
20. Williams M.L., Rimm D.L., Pedigo M.A., Frable W.J. Atypical squamous cells of undetermined significance: correlative histologic and follow-up studies from an academic medical center. Diagn Cytopathol 1997, 16:1-7.
21. Lachman M.F., Cavallo-Calvanese C. Qualification of atypical squamous cells of undetermined significance in an independent laboratory: is it useful or significant?. Am J Obstet Gynecol 1998, 179:421-429.
22. Nyirjesy I., Billingsley F.S., Forman M.R. Evaluation of atypical and low-grade cervical cytology in private practice. Obstet Gynecol 1998, 92:601-607.
23. Eltabbakh G.H., Lipman J.N., Mount S.L., Morgan A. Significance of atypical squamous cells of undetermined significance on ThinPrep papanicolaou smears. Gynecol Oncol 2000, 79:44-49.
24. Gerber S., De Grandi P., Petignat P., Mihaescu A., Delaloye J.F. Colposcopic evaluation after a repeat atypical squamous cells of undetermined significance (ASCUS) smear. Int J Gynaecol Obstet 2001, 75:251-255.
25. Smith-McCune K., Mancuso V., Contant T., Jackson R. Management of women with atypical Papanicolaou tests of undetermined significance by board-certified gynecologists: discrepancies with published guidelines. Am J Obstet Gynecol 2001, 185:551-556.
26. Marcus A.C., Crane L.A., Kaplan C.P., Reading A.E., Savage E., Gunning J., et al. Improving adherence to screening follow-up among women with abnormal Pap smears: results from a large clinic-based trial of three intervention strategies. Med Care 1992, 30:216-230.
27. Lerman C., Hanjani P., Caputo C., Miller S., Delmoor E., Nolte S., et al. Telephone counseling improves adherence to colposcopy among lower-income minority women. J Clin Oncol 1992, 10:330-333.
28. Massad L.S., Meyer P.M. Predicting compliance with follow-up recommendations after colposcopy among indigent urban women. Obstet Gynecol 1999, 94:371-376.
29. Melnikow J., Chan B.K., Stewart G.K. Do follow-up recommendations for abnormal Papanicolaou smears influence patient adherence?. Arch Fam Med 1999, 8:510-514.
30. Kalantar J.S., Talley N.J. The effects of lottery incentive and length of questionnaire on health survey response rates: a randomized study. J Clin Epidemiol 1999, 52:1117-1122.
31. Siemiatycki J., Campbell S. Non-response bias and early versus all responders in mail and telephone surveys. Am J Epidemiol 1984, 120:291-301.